Monitor upcoming proxy filings for full director compensation details and any further governance changes. The addition of Epstein with M&A and capital markets expertise may signal strategic development plans, though no immediate financial impact is expected.
Price Chart
Executive Summary
Onconetix, Inc. announced the resignation of directors Andrew Oakley and Thomas Meier, the appointment of Sammy Dorf as Chairman of the Board with $20,000 annual compensation, and the election of Josh Epstein to the Board and its committees. The changes reflect a board refreshment with no disclosed disagreements or operational issues.
Key Facts
- Andrew Oakley and Thomas Meier resigned from the Board of Directors effective April 20, 2026, with no disagreements reported.
- Sammy Dorf was appointed Chairman of the Board effective April 23, 2026, and will receive $20,000 per year in compensation.
- Josh Epstein was elected to the Board and named chair of the Nominating and Corporate Governance Committee, bringing extensive cross-industry executive and legal experience.
- Epstein's compensation will be consistent with other non-employee directors.
- Oakley also stepped down as Chairman and from the Audit, Compensation, and Nominating Committees; Meier resigned from the Compensation Committee.
Financial Impact
Minimal; $20,000 annual increase in director compensation
Risk Factors
- Potential loss of institutional investor confidence if board stability is perceived as weak
- Integration risk of new directors into key committees
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-047577 |
| Document: 0001213900-26-047577-index-headers.html | 0001213900-26-047577 |
| Document: 0001213900-26-047577-index.html | 0001213900-26-047577 |
| Document: 0001213900-26-047577.txt | 0001213900-26-047577 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | DEFA14A / 8-K | $0.6374 $0.6549 | ▲ +2.75% | ▲ +2.64% | $0.7440 (+16.72%) |
Sep 14, 2026 18d ago | 8-K | $0.6374 $0.6549 | ▼ −2.75% | ▼ −2.64% | $0.7440 (−16.72%) |
Sep 14, 2026 18d ago | 425 | $0.6374 $0.6549 | ▼ −2.75% | ▼ −2.64% | $0.7440 (−16.72%) |
Sep 4, 2026 28d ago | EFFECT | $1.02 $0.6374 | ▲ +37.51% | ▲ +36.30% | $0.7440 (+27.06%) |
Sep 3, 2026 29d ago | 425 | $0.7390 $0.7564 | ▲ +2.35% | ▲ +3.50% | $0.7440 (+0.68%) |
Aug 31, 2026 4w ago | S-1/A | $0.6528 $0.8132 | ▼ −24.57% | ▼ −24.49% | $0.7440 (−13.97%) |
Aug 12, 2026 7w ago | S-1 | $0.8920 $0.7110 | ▲ +20.29% | ▲ +19.85% | $0.7440 (+16.59%) |
Jul 29, 2026 9w ago | 8-K | $0.7864 $0.9037 | ▼ −14.92% | ▼ −11.29% | $0.7440 (+5.39%) |
Jul 7, 2026 12w ago | 425 | $1.07 $0.8487 | ▼ −20.68% | ▼ −21.23% | $0.7440 (−30.47%) |
Jun 17, 2026 15w ago | EFFECT | $0.9949 $1.00 | ▼ −0.51% | ▼ −1.55% | $0.7440 (+25.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access